Credentialing of nuclear medicine physicians, surgeons, and pathologists as a multidisciplinary team for selective sentinel lymphadenectomy.

Masaki Kitajima, Yuukou Kitagawa, Hirofumi Fujii, Makio Mukai, Atsushi Kubo

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

There are several possible applications of the sentinel lymph node (SLN) concept with different technological aspects such as individualized surgical management of solid tumors, multidisciplinary treatments, and novel therapeutic approaches. To achieve these clinical applications, multidisciplinary teamwork with surgeons, nuclear medicine physicians, and pathologists would be critically required. Interdisciplinary issues should be resolved in order to develop optimal standard procedures of SLN dissection for various solid tumors.

Original languageEnglish
Pages (from-to)253-267
Number of pages15
JournalCancer Treatment and Research
Volume127
Publication statusPublished - 2005

Fingerprint

Credentialing
Nuclear Medicine
Lymph Node Excision
Physicians
Neoplasms
Therapeutics
Pathologists
Surgeons
cyhalothrin
Sentinel Lymph Node

Cite this

Credentialing of nuclear medicine physicians, surgeons, and pathologists as a multidisciplinary team for selective sentinel lymphadenectomy. / Kitajima, Masaki; Kitagawa, Yuukou; Fujii, Hirofumi; Mukai, Makio; Kubo, Atsushi.

In: Cancer Treatment and Research, Vol. 127, 2005, p. 253-267.

Research output: Contribution to journalArticle

@article{95f35148555448e29b77b7ec55ce8da1,
title = "Credentialing of nuclear medicine physicians, surgeons, and pathologists as a multidisciplinary team for selective sentinel lymphadenectomy.",
abstract = "There are several possible applications of the sentinel lymph node (SLN) concept with different technological aspects such as individualized surgical management of solid tumors, multidisciplinary treatments, and novel therapeutic approaches. To achieve these clinical applications, multidisciplinary teamwork with surgeons, nuclear medicine physicians, and pathologists would be critically required. Interdisciplinary issues should be resolved in order to develop optimal standard procedures of SLN dissection for various solid tumors.",
author = "Masaki Kitajima and Yuukou Kitagawa and Hirofumi Fujii and Makio Mukai and Atsushi Kubo",
year = "2005",
language = "English",
volume = "127",
pages = "253--267",
journal = "Cancer Treatment and Research",
issn = "0927-3042",
publisher = "Springer Netherlands",

}

TY - JOUR

T1 - Credentialing of nuclear medicine physicians, surgeons, and pathologists as a multidisciplinary team for selective sentinel lymphadenectomy.

AU - Kitajima, Masaki

AU - Kitagawa, Yuukou

AU - Fujii, Hirofumi

AU - Mukai, Makio

AU - Kubo, Atsushi

PY - 2005

Y1 - 2005

N2 - There are several possible applications of the sentinel lymph node (SLN) concept with different technological aspects such as individualized surgical management of solid tumors, multidisciplinary treatments, and novel therapeutic approaches. To achieve these clinical applications, multidisciplinary teamwork with surgeons, nuclear medicine physicians, and pathologists would be critically required. Interdisciplinary issues should be resolved in order to develop optimal standard procedures of SLN dissection for various solid tumors.

AB - There are several possible applications of the sentinel lymph node (SLN) concept with different technological aspects such as individualized surgical management of solid tumors, multidisciplinary treatments, and novel therapeutic approaches. To achieve these clinical applications, multidisciplinary teamwork with surgeons, nuclear medicine physicians, and pathologists would be critically required. Interdisciplinary issues should be resolved in order to develop optimal standard procedures of SLN dissection for various solid tumors.

UR - http://www.scopus.com/inward/record.url?scp=27244432201&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27244432201&partnerID=8YFLogxK

M3 - Article

VL - 127

SP - 253

EP - 267

JO - Cancer Treatment and Research

JF - Cancer Treatment and Research

SN - 0927-3042

ER -